HER2-positive T cell mediated adaptive therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-positive T cell mediated adaptive therapy, covering 2016-01-25 to 2016-01-25. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]